Attention Deficit Hyperactivity Disorder (ADHD) is the most common childhood neuropsychiatric disorder. Yet there is currently no tool that will confirm the diagnosis of ADHD. In her thesis entitled “Development of a genotyping system to be applied in Attention Deficit Hyperactivity Disorder and its Pharmacogenetics" (“Desarrollo de un sistema de genotipado para la aplicación en el ‘trastorno por déficit de atención con hiperactividad’ y su farmacogenética”), the researcher Alaitz Molano, a graduate in biochemistry and PhD holder in Pharmacology from the UPV/EHU-University of the Basque Country, presents a tool that could improve not only the diagnosis of but also the therapeutics for this disorder.
Scientists from Freiburg Build a Microimplant that Uses a Laser to Control Individual Nerve Cells
Technology originally designed by NASA Glenn scientists to monitor the health of astronauts is finding new applications here on Earth that could significantly impact the safety of pilots and the rehabilitation of cardio-pulmonary patients.
ICU Medical, Inc. today announced it will launch the CardioFlo hemodynamic monitoring sensor system at the Society of Critical Care Medicine (SCCM) Critical Care Congress in San Juan, Puerto Rico, January 19-23, 2013.
Zimmer Holdings, Inc., a global leader in musculoskeletal health, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market iASSIST™ Knee, the Personalized Guidance System™ for knee replacement procedures.
Arizona State University’s Biodesign Institute has announced a partnership with Life Technologies Corporation as it enters the next phase of a multi-million-dollar, multi-institutional research project to develop a medical device to rapidly assess an individual’s exposure to radiation in the event of a nuclear incident.
Wearable body monitoring pioneer BodyMedia today announced the BodyMedia CORE 2, the next generation of the activity/health tracker armband used on The Biggest Loser®. Packing four sensors into a housing smaller than an iPod Nano, the CORE 2 will be the smallest wearable multi-sensor device of its kind as well as the first to offer a choice of interchangeable jewelry- like faceplates, straps and cuffs for a fashion look.
PhysioSonics announced today the U.S. Food and Drug Administration has granted the Presto 1000 Flow Monitor system 510k clearance for cranial blood flow monitoring. In addition, the company announced completion of Series B add-on debt financing, closing with $1.05 million.
Masimo today announced that Ogden Regional Medical Center (ORMC), named by The Joint Commission as a Top Performer on Key Quality Measures™, has standardized to Masimo rainbow® Pulse CO-Oximetry™ and sensor technologies for advanced patient monitoring.
T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued patent number 8,334,693 (the ‘693 patent), “NMR device for detection of analytes”.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.